It has been suggested that EGFR/TP53/RB1 mutant lung cancers have a unique risk of histological transformation, with 25% of lung cancers exhibiting ab initio small cell lung cancer or eventual small cell transformation.23 This evidence concerns the gene TP53 and lung carcinoma.